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Central pontine myelinolysis is an acquired demyelinating disorder of uncertain
origin that predominantly affects the centre of the basilar portion of the pons.
Several theories have been proposed to account for this condition, prominent
among them being abnormalities in serum sodium concentration. We report
on a patient who had central pontine myelinolysis with extrapontine lesions and
Wernicke's encephalopathy but who maintained a normal or high serum sodium
concentration throughout his hospital admission.
CASE REPORT. A 52-year-old man was admitted to hospital following two
tonic-clonic seizures. There was a long history of excessive alcohol consumption
of more than 100 units per week. One week prior to admission he had stopped
drinking alcohol because he had become increasingly confused. He was on no
regular medication. There was no history of trauma or epilepsy. On examination
he was apyrexic, anicteric and not clinically dehydrated. He scored 11 on the
Glasgow Coma scale.' There were no abnormal neurological signs in the cranial
nerves. Tone in the limbs was flaccid with hyporeflexia and flexor plantar
responses. Sensation was intact. He became agitated and was commenced on
multiple vitamin supplements and 40 mg chlordiazepoxide on a decreasing
regimen. Initial investigations showed serum sodium 139 mmol/l, potassium 2
-9
mmol/l, glucose 6-7 mmol/l and urea 6-9 mmol/l. Liver function tests were
normal apart from serum gamma-glutamyl transferase 236 U/I (usual range
7-46).
Despite an adequate oral fluid intake he became more confused. He was
disorientated in place and time and was unable to recognise his relatives. There
was no asterixis or hepatic fetor. Serum ammonia was 57 pmol/l (13-52).
Electroencephalography showed a mild generalised abnormalityofa non -specific
nature. CT scan of the brain revealed no evidence of intracranial haemorrhage or
central pontine myelinolysis. Magnetic resonance imaging was not performed.
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He remained confused and on the seventh hospital day developed a right basal
pneumonia. Despite intravenous antibiotics he continued to deteriorate and died
seven days later from cardiac arrest.
Throughout the 14 days his serum sodium concentration was measured daily
or every second day and gradually rose from 139 mmol/l to 153 mmol/l. Liver
enzymes remained approximately constant.
At necropsy the liver (1420 g) showed micronodular cirrhosis with fatty change
and Mallory's hyaline deposits in the hepatocytes. Coronal slicing of the brain
(1414g) revealed no macroscopic haemorrhagic necrosis or atrophy of the
mamillary bodies. Histologically the mamillary bodies and periventricular gray
mattershowedcharacteristic changesofWernicke'sencephalopathy withcapillary
prominence, ring haemorrhages, astrocytic gliosis and foamy macrophages. In
the cerebellum there was atrophy ofthe anterior superior vermis with widespread
Purkinje cell loss, proliferation of Bergman astrocytes, mild granular cell loss
and isomorphic gliosis in the molecular layer. The pons on horizontal sectioning
showed a roughly triangular area of granular softening disposed symmetrically
in the centre of the basis pontis (Fig 1). Sections from this area showed
clearly defined incomplete demyelination, mainly involving the transverse ponto-
cerebellar fibres: there was a total loss of oligodendrocytes with both focal
macrophage and reactive astrocyte infiltration. The tegmentum was not involved.
Foci of myelinolysis were also seen throughout the subcortical white matter in the
frontal, temporal and parietal areas and in the internal capsule. Electron micro-
scopy of the edges of these subcortical lesions revealed many myelin sheaths
undergoing vesicular tubular myelinolysis (Fig 2) and acute necrosis of some
accompanying oligodendroglia.
Fig 1 (above). Transverse section of midpons show.
ing central area of demyelination.
Fig 2 (right). Electron micrograph (X 20,500) show -
ing vesicular
- tubular myelin breakdown in a sub-
cortical white matter lesion.
DISCUSSION
This patient presented with clinical features of central pontine myelinolysis,
namely, an acute confusional state, seizures, flaccid quadriparesis and a history
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of chronic alcohol use. Wernicke's encephalopathy does not completely explain
his mental confusion as the confusion progressed despite rapidly administered
intravenous thiamine. Also seizures and flaccid quadriparesis are not features of
Wernicke's encephalopathy.2 The clinical spectrum of central pontine myelin-
olysis includes coma, the "locked-in" syndrome, seizures, facial weakness,
pseudobulbar palsy, quadriparesis and behavioural changes without focal
signs.3 4,5 The rapid neurological deterioration in this case is typical of central
myelinolysis. In other cases reported most of the demyelinating lesions have
evolved in two to four weeks.4
There is no diagnostic test for central pontine myelinolysis. The CT scan may be
normal as in this case, or may show a non-enhancing hypodense lesion in the
ventral pons.6 Magnetic resonance imaging ismore sensitivethan CTinvisualising
the pontine lesion but may also be normal early in the course ofthe disease.7 Few
cases of central pontine myelinolysis are diagnosed in life probably because the
clinical manifestations are obscured by other neurological abnormalities, or are
absent if the lesion is small.3 5
The initial reports of central pontine myelinolysis coincided with the first wide-
spread use of intravenous therapy to treat electrolyte abnormalities.8 In particular
central pontine myelinolysis has been reported as developing when a low serum
sodium concentration is increased at a rate greater than 12 mmol/1 /day.9
However, other authors argue that rapid correction of hyponatraemia in itself is
not dangerous, provided that hypernatraemia does not develop during the first
48 hours of therapy.'0 Hyponatraemia alone has been blamed for producing the
condition."I In animals pontine and extra-pontine myelinolysis can be induced
more easily by rapid correction of chronic than of acute hyponatraemia.'2 The
rapid correction of chronic hyponatraemia results in dehydration whereas rapid
correction of acute hyponatraemia reduces to normal the levels of water in the
brain. This rapid change in the levels of water in the brain is thought to be an
essential component in the pathogenesis of central pontine myelinolysis.
Alteration in serum sodium concentration cannot be excluded as an aetiological
factor in our patient, as it may have occurred prior to his hospital admission.
However, many recently reported series of central pontine myelinolysis have
included cases with normal serum sodium. McKee and colleagues found the
characteristic pontine and extra-pontine lesions in ten patients who died from
severe burns,5 and hyponatraemia was not present in any of these patients.
Central pontine myelinolysis is invariably associated with some other serious,
often life-threatening disease. The condition was initially described in 1959 in
alcoholic and malnourished individuals with liver disease.4 In more than half the
cases it appeared in the late stages of chronic alcoholism, often co -existing with
Wernicke's encephalopathy. Other frequently noted associations are patients
with hepatic cirrhosis, Wilson's disease,'3 chronic renal failure, severe burns,5
lymphoma, carcinoma, leukaemia,'4 acute haemorrhagic pancreatitis and as a
complication of renal 15 or liver'6 transplantation. These disorders may result in
abnormalities of astrocyte metabolism with a reduced ability to generate new
intracellular anions in response to osmotic change.'7 Demyelination may then
develop when a rapid change in serum osmolality results in osmotic endothelial
injury and opening of the blood -brain barrier. This would allow entry of myelino -
toxic factors from the bloodstream and also generate vasogenic cerebral oedema,
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a known precipitant of demyelination. The rapid change in serum osmolality may
be due to anions other than sodium, or to uraemia or hyperglycaemia. Individual
variation in the reaction of central nervous tissue to similar degrees of osmotic
stress may determine susceptibility. At present this is speculative but until these
mechanisms are elucidated it will not be possible to predict who might develop
central pontine myelinolysis.
It is important to consider the possibility of central pontine myelinolysis in any
severely ill patient who develops an unexplained behavioural disorder with or
without neurological signs. There is no specific treatment but major fluctuations
in serum osmolality should be avoided as clinical and radiological recovery from
central pontine myelinolysis is possible.7 18
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